跳到主要內容

Summer Road LLC 的 Form 4 申報

Ocular Therapeutix, Inc(OCUL),2022/1/31 申報

申報編號
0001567619-22-002090
申報時間
2022/1/31
交易日
2022/1/27-1/28
申報延遲
4 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 2 筆非衍生性交易。公開市場買進合計 $2.86 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Summer Road LLCCIK 0001604873持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/1/27Common Stock, $0.0001 par value per shareP買進取得+1,477$5.20F4+$7,680.45,890,738間接
2022/1/28Common Stock, $0.0001 par value per shareP買進取得+4,023$5.20F5+$20,919.65,894,761間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F4

Represents the weighted average set forth in this line item. On January 27, 2022, the Reporting Person acquired 1,477 shares of Common Stock at a weighted average price of $5.20 (ranging from a low of $5.20 and a high of $5.62). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents the weighted average set forth in this line item. On January 28, 2022, the Reporting Person acquired 4,023 shares of Common Stock at a weighted average price of $5.20 (ranging from a low of $5.12 and a high of $5.35). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)